Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany
· Delayed Price · Currency is EUR 463.30
+8.25 (1.81%)
Feb 21, 2025, 5:35 PM CET
Vertex Pharmaceuticals Revenue
In the year 2024, Vertex Pharmaceuticals had annual revenue of $11.02B USD with 11.66% growth. Vertex Pharmaceuticals had revenue of $2.91B in the quarter ending December 31, 2024, with 15.66% growth.
Revenue
$11.02B
Revenue Growth
+11.66%
P/S Ratio
n/a
Revenue / Employee
$1.81M
Employees
6,100
Market Cap
118.98B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.02B | 1.15B | 11.66% |
| Dec 31, 2023 | 9.87B | 938.50M | 10.51% |
| Dec 31, 2022 | 8.93B | 1.36B | 17.91% |
| Dec 31, 2021 | 7.57B | 1.37B | 22.06% |
| Dec 31, 2020 | 6.21B | 2.04B | 49.08% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Siemens Healthineers AG | 22.67B |
| Merck KGaA | 20.96B |
| Bayer Aktiengesellschaft | 46.74B |
| Fresenius SE & Co. KGaA | 22.81B |
| Sartorius Aktiengesellschaft | 3.38B |
| Fresenius Medical Care AG | 19.24B |
| Carl Zeiss Meditec AG | 2.08B |
| Fielmann Group AG | 2.16B |
Vertex Pharmaceuticals News
- 2 days ago - Insider Sell: Jonathan Biller Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
- 4 days ago - Vertex to Participate in Upcoming March Investor Conferences - Business Wire
- 4 days ago - High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models - CNBC
- 8 days ago - Levi & Korsinsky Announces an Investigation on Behalf of Vertex Pharmaceuticals Incorporated (VRTX) Shareholders Who May Have Been Affected by Fraud - Accesswire
- 8 days ago - Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing - The Motley Fool
- 8 days ago - Capital World Investors Expands Stake in Vertex Pharmaceuticals - GuruFocus
- 9 days ago - Vertex Pharmaceuticals Incorporated Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - VRTX - Accesswire
- 10 days ago - Insider Sell: Kristen Ambrose Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus